Q Interventional Technologies (QiTec) portfolio of products is characterised by a focus on percutaneous or minimally invasive solutions, including endoscopic techniques, for spinal & musculo-skeletal pathologies. Our initial product offering includes devices for Epiduroscopy, Spinal Disc Decompression, Electrical Nerve and Stimulation.
Whilst we at QiTec recognise that a pain-free world remains a distant concept, we have committed our energies towards providing alternative tools in the spectrum of capabilities available to pain management professionals, that aim to provide lasting relief to patients debilitated by chronic pain.
Our criteria for product selection are rigorous, and ultimately centred around the delivery of a positive patient outcome. Critical to this process is education of the surgical & theatre teams in the correct and optimal use of the technology, and QiTec proudly partners with our customers and partners to ensure that this is delivered, via workshops and dedicated training sessions.
Andy Caudell is the Managing Director of Q Interventional Technologies Ltd.
He is a Medical Device industry veteran, with close to 30 years international sales & marketing and leadership experience, within the orthopaedic, spine and medical device sectors.
He has worked within blue-chip multinational corporations, as well as advising and leading start-up medtech organisations into EMEA markets, resulting a number of successful exits in the sector.
His extensive network of clinical and industry contacts within the medtech sector ideally positions Q Interventional Technologies to access and deliver the most innovative and effective products available to the UK & Irish healthcare community, and secure lasting relationships with their stakeholders.
Kristin Stovold is the UK Market Development Manager at Q Interventional Technologies Ltd.
He has 25 years experience in sales and technical expertise within electronic engineering, neuromodulation, spine & orthopedic sectors.
For the last 8 years Kristin has worked alongside multiple neuromodulation companies within various device and clinical sectors, including both implantable and external stimulation devices for treatment of chronic pain, and bladder and bowel disorders.
With an extensive network of clinical contacts across multiple sectors including chronic pain, neuro surgery, urology and gynaecology, his deep understanding of NHS clinical and procurement practices enables us to navigate complex public sector approaches, commercialising novel technologies & steering the rapid scale-up of business.
Charlie Pillans is the Chief Executive Officer of the Pillans Group Ltd, which operates in several industries ranging from Medical Devices to Surgical Implants distribution, through to Organisational Optimisation, and Environmental Projects centred around Medical Manufacturing.
Throughout his career he has consistently developed strong businesses within the UK and further afield.
With a proven sales & marketing track record, both within blue chip and start-up companies, and an emphasis on accelerated strategies to fast-track medical products into the NHS procurement network, he is regarded as one of the most innovative and visionary leaders currently operating in his fields of interest, amongst his peers.